MARKET

IBB

IBB

iShares Nasdaq Biotechnology ETF
NASDAQ

Real-time Quotes | Provided by Morningstar

173.61
+1.10
+0.64%
After Hours: 173.30 -0.31 -0.18% 19:59 09/17 EDT
OPEN
172.94
PREV CLOSE
172.51
HIGH
173.74
LOW
170.69
VOLUME
4.45M
TURNOVER
--
52 WEEK HIGH
177.37
52 WEEK LOW
128.23
TOTAL ASSET
11.28B
YTD YIELD
8.08%
1D
5D
1M
3M
1Y
5Y
Indaptus Therapeutics stock nearly triples on heavy volume after allowance for patent of platform technology
Shares of Indaptus Therapeutics Inc. nearly tripled on massive volume in midday trading, to bounce off the previous session's record closing low, after the developer of treatments for hepatitis and HIV announced the allowance of a patent for its platform t...
Marketwatch.com · 2d ago
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?
Zacks.com · 2d ago
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13)
Benzinga · 3d ago
Sector Update: Health Care Stocks Rally Early Tuesday
MT Newswires · 3d ago
Moderna ETFs to Rally on Two-in-One Vaccine Booster Shot News
Zacks.com · 5d ago
Sector Update: Health Care Stocks Advance Premarket Friday
MT Newswires · 09/10 09:17
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8)
Benzinga · 09/09 12:17
Sector Update: Health Care Stocks Slip Pre-Bell Thursday
MT Newswires · 09/09 09:22
More
No Data
Learn about the latest financial forecast of IBB. Analyze the recent business situations of iShares Nasdaq Biotechnology ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
08/31/2020
10 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-3.6936%
--
1-Week
-1.9739%
--
1-Month
-6.1662%
--
3-Month
-1.8936%
--
6-Month
11.9477%
--
YTD
8.0849%
--
1-Year
29.1046%
--
3-Year
5.3735%
--
5-Year
3.1086%
--
10-Year
17.0547%
--
Since Inception
7.3696%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
iShares Nasdaq Biotechnology ETF
Risk
Medium-high risk
Inception Date
2001-02-05
Benchmark
Dow Jones US Healthcare TR
Advisor Company
iShares
Custodian
State Street Bank & Trust Co
Manager
Team Managed